Pliant Therapeutics, Inc. (PLRX)
NASDAQ·Healthcare·Biotechnology
$1.22
+0.41%
Mkt Cap $74.92M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 11, 2026 | $5.00M | — | — | -$0.42 | -$0.35 | +16.67% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.53 | -$0.43 | +18.87% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.62 | -$0.71 | -14.52% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.78 | -$0.92 | -17.95% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.99 | -$0.82 | +17.17% | — | — |
| Q4 2024 Nov 7, 2024 | $83.33K | — | — | -$0.99 | -$0.95 | +4.04% | — | — |
| Q3 2024 Aug 7, 2024 | $490.00K | — | — | -$0.85 | -$0.92 | -8.24% | — | — |
| Q2 2024 May 6, 2024 | $460.00K | — | — | -$0.76 | -$0.78 | -2.63% | — | — |
| Q1 2024 Feb 27, 2024 | $814.11K | $4.84M | +494.51% | -$0.81 | -$0.69 | +14.81% | — | — |
| Q4 2023 Nov 9, 2023 | $460.00K | — | — | -$0.78 | -$0.70 | +10.26% | — | — |
| Q3 2023 Aug 9, 2023 | $880.00K | $248.00K | -71.82% | -$0.73 | -$0.70 | +4.11% | — | — |
| Q2 2023 May 9, 2023 | $1.21M | $1.33M | +10.08% | -$0.66 | -$0.67 | -1.52% | — | — |
| Q1 2023 Mar 9, 2023 | $1.45M | $1.97M | +35.46% | -$0.70 | -$0.72 | -2.86% | — | — |
| Q4 2022 Nov 8, 2022 | $1.79M | $1.48M | -17.32% | -$0.74 | -$0.65 | +12.16% | — | — |
| Q3 2022 Aug 8, 2022 | $1.35M | $4.99M | +269.59% | -$0.82 | -$0.82 | +0.00% | — | — |
| Q2 2022 May 9, 2022 | $1.26M | $1.25M | -0.87% | -$0.77 | -$0.78 | -1.30% | — | — |
| Q1 2022 Feb 28, 2022 | $3.00M | $2.00M | -33.37% | -$0.76 | -$0.68 | +10.53% | — | — |
| Q4 2021 Nov 9, 2021 | $1.75M | $1.61M | -8.00% | -$0.71 | -$0.75 | -5.63% | — | — |
| Q3 2021 Aug 9, 2021 | $1.79M | $1.79M | +0.00% | -$0.64 | -$0.64 | +0.00% | — | — |
| Q2 2021 May 10, 2021 | $2.03M | $2.17M | +7.14% | -$0.59 | -$0.64 | -8.47% | — | — |